Mark Carter has 30 years experience working in management and consulting across the health care industry. He has played a key role in the development of the delivery system, innovation and public policy in the greater Louisville area. He has considerable insight into a myriad of issues facing the system.
 | David Myre on Unfortunate Acronyms, Money Ta… |
 | mbcarter57 on Rage, Rage Against the Dying o… |
 | John on Rage, Rage Against the Dying o… |
 | Lisa on The Importance of Leadership i… |
 | bruce patterson on Wow! What a Month! |
“Medicine is for the patients…the profits follow.” So said George Merck II, then CEO of pharmaceutical giant Merck & Company, sometime during the first half of the 1900s. Merck, in those days, hoarded cash for investment in research and development and followed a corporate philosophy that focused first on improving the human condition. Merck believed [...]
Filed under: Recent Posts | Tagged: Avandia, GlaxoSmithKline, Merck, Time, Vioxx | Leave a Comment »
